AJAX progress indicator
  • Biosimilar MedicineA biosimilar medicine is a biological medicine which is similar to another biological medicine that has already been authorised for use. Biosimilar medicines are commonly known as biological generic medicines. The existing biological medicine is known as the ‘reference medicinal product’.(...)
  • BiotechnologyAny technological application of living systems, biological processes or organisms, to develop or make useful products or new technologies.
  • BiotransformationBiotransformation is the process whereby a substance is changed (transformed) from one chemical to another by a chemical reaction within the body. Biotransformation is vital to survival because absorbed nutrients (food, oxygen, etc.) are transformed into substances required for normal body(...)
  • BlindingBlinding is a way of making sure that the people involved in a research study, such as the participants in clinical trials, do not know which trial arm they are assigned to. For example, in a trial with one treatment arm and one placebo arm, blinding means that the participants do not know if(...)
  • Bona fideCarried out in good faith; honest, without fraud or deception.
  • Branded MedicinesBranded medicines are medicines which have a name given to them by a company for the purpose of advertising. The names of branded medicines are different from the International Nonproprietary Name (INN), also known as the generic name. Branded medicines may be the original medicine developed(...)
  • Budget impactCosts within a particular timeframe and related to a particular healthcare budget rather than a country’s overall budget. This assumes robust data on epidemiology and treatment patterns, along with assumptions of uptake and displacement of current treatments.
  • Bulgarian Drug AgencyBulgarian National Competent Authority."
  • BDABulgarian National Competent Authority."
  • Bundesamt für Sicherheit im GesundheitswesenAustrian National Competent Authority."

Find Out More